arrow
Return

The Gut Microbiota Is Altered in Antidepressant-Free Depressed Patients and Is Associated With Depression Severity

delete2025-07-28
delete0
delete
OA
AI
S
Sofia Cussotto *
R
Romain Colle
C
Cosmin Sebastian Voican
D
Dragos Ciocan
N
Nicolas Trainel
H
Hugo Bottemanne
Y
Yann Pelloux
D
Denis J. David
A
Anne‐Marie Cassard
G
Gabriel Perlemuter
E
Emmanuelle Corruble
DOI:10.1111/jnc.70173delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Interest in the microbiota-gut-brain axis is increasing, but data on the associations between the microbiota and major depressive disorder (MDD), particularly in relation to symptomatology and treatment response, remain scarce and inconsistent. This study aims at characterizing the gut microbiota of antidepressant-free MDD patients with a Major Depressive Episode (MDE) in comparison to healthy controls (HCs) and to investigate whether microbiota composition is associated with depression severity. Twenty-five adults with a current MDE, who had been antidepressant-free for at least 1 month, were evaluated for both depression severity and fecal microbiota composition using 16S rRNA sequencing. Their microbiota profiles were compared with those of twenty-eight HCs. Psychiatric assessments were conducted at baseline using the Hamilton Depression Rating Scale (HDRS) and the Clinical Global Impression (CGI) scale. Compared to HCs, MDE patients showed no significant differences in microbial alpha diversity. However, alterations in the relative abundance of several taxa, including Lachnospiraceae and Bifidobacteriaceae, along with an increase in Bifidobacterium, were detected. Beta-diversity analyses (PCoA plot) identified two distinct compositional clusters. Significant alterations were found in 7 out of 25 families and 20 out of 61 genera, with a notable decrease of the Lachnospiraceae NK4A136 genus in MDE patients, which was associated with worse symptom severity. These findings reveal distinct alterations in the gut microbiota of antidepressant-free MDE patients compared to HCs, particularly in key phyla and families. They suggest that the gut microbiota may represent a novel target for the management and treatment of MDD.
Keywords:
antidepressant-free
gut-brain axis
Lachnospiraceae NK4A136
major depressive episode
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Journal of Neurochemistry cover
Journal of Neurochemistry
IF:
4
Papers:
465
Citations:
3.0W

Organization

F
faculté de pharmacie
Scholars:
48
Papers: 22
Citations: 1
F
faculté de médecine
Scholars:
149
Papers: 77
Citations: 0
U
université paris-saclay
Scholars:
2.2K
Papers: 898
Citations: 1
researcher View more organizations